WorldCat Identities

Conaghan, Philip (Philip G.)

Works: 14 works in 40 publications in 2 languages and 2,938 library holdings
Genres: Popular works 
Roles: Author
Classifications: RC931, 616.3999
Publication Timeline
Most widely held works by Philip Conaghan
Fast facts : osteoarthritis by Philip Conaghan( Book )

16 editions published between 2007 and 2017 in English and held by 110 WorldCat member libraries worldwide

For all healthcare professionals who have ever felt unable to provide effective therapy for this disease, or who have encountered negative patient and community attitudes to joint pain, Fast Facts: Osteoarthritis is essential reading
Musculoskeletal imaging by Philip Conaghan( Book )

6 editions published in 2010 in English and held by 63 WorldCat member libraries worldwide

Diseases of the joints and surrounding tissues cannot be visualised without the help of imaging techniques. These range from x-rays (which have been available for over 100 years) to the highly sophisticated magnetic resonance imaging scanning. The variety of imaging techniques and indeed the quality of these images has improved radically in the past decade and this book attempts to capture the way in which rheumatologists and their colleagues can use a wide variety of techniques toanalyse musculoskeletal diseases which are known to exist. This handbook provides the reader with an insight into both which imaging techniques should be applied to particular clinical problems and how the results can be used to determine the diagnosis and management of musculoskeletal conditions. It is extensively illustrated with examples of the various imaging techniques and joints to aid understanding, and is organised by anatomical region and specific musculoskeletal disorder to allow easy access to information
Principles of non-pharmacological management of musculoskeletal conditions( Book )

2 editions published in 2008 in English and held by 6 WorldCat member libraries worldwide

New treatments in arthritis by Philip Conaghan( Book )

1 edition published in 2003 in English and held by 5 WorldCat member libraries worldwide

Clinical, radiographic and immunogenic effects after 1 year of tocilizumab-based treatment strategies in rheumatoid arthritis: the ACT-RAY study by Maxime Dougados( )

1 edition published in 2014 in English and held by 2 WorldCat member libraries worldwide

Osteoarthritis research priorities: a report from a EULAR ad hoc expert committee by Philip Conaghan( )

1 edition published in 2014 in English and held by 2 WorldCat member libraries worldwide

MRI and ultrasound in rheumatoid arthritis( )

1 edition published in 2016 in English and held by 1 WorldCat member library worldwide

Abstract : Purpose of review: To overview the recent literature on the use of MRI and musculoskeletal ultrasonography (MSUS) in rheumatoid arthritis. Recent findings: Subclinical inflammation has been widely confirmed, even in the earliest phases of rheumatoid arthritis. The presence of osteitis has added benefits to modern diagnostic criteria, and anticitrullinated peptide antibody positive patients have demonstrated higher osteitis scores. A model for prediction of rheumatoid arthritis onset employing usual clinical data and power Doppler ultrasonography has been reported. The presence of tenosynovitis may also be an early finding in rheumatoid arthritis. Modern imaging continues to inform our concept of pathogenesis with reports on the direct relationship of synovitis to cartilage proteoglycan loss using compositional MRI measures. Growing data on the validity of MRI as an important predictor of clinical and radiographic damage endpoints has been reported and reflected in the growing use of this outcome in many contemporary biologic therapy trials. Much work has been presented on improved and validated MSUS scores with reduced and feasible joint counts. The role of ultrasonography in making sensible decisions when monitoring biologic use, and in tapering, has been reported. Summary: The recent literature demonstrates improved validity and utility for both MRI and MSUS in diagnosis, prognosis and monitoring of rheumatoid arthritis
Reumatología by Paul Emery( Book )

in Spanish and held by 1 WorldCat member library worldwide

Autoantibodies to Posttranslationally Modified Type II Collagen as Potential Biomarkers for Rheumatoid Arthritis( )

1 edition published in 2013 in English and held by 1 WorldCat member library worldwide

Abstract : Objective: Type II collagen (CII) posttranslationally modified by reactive oxygen species (ROS‐CII) that are present in the inflamed joint is an autoantigen in rheumatoid arthritis (RA). The aim of this study was to investigate the potential use of anti–ROS‐CII autoantibodies as a biomarker of RA. Methods: CII was exposed to oxidants that are present in the rheumatoid joint. Autoreactivity to ROS‐CII was assessed by enzyme‐linked immunosorbent assays in synovial fluid (SF) and serum samples obtained from patients during various phases of RA. This group included disease‐modifying antirheumatic drug (DMARD)–naive patients with early RA (n = 85 serum samples) and patients with established RA (n = 80 serum and 50 SF samples), who were categorized as either DMARD responders or DMARD nonresponders. Control subjects included anti–citrullinated protein antibody (ACPA)–positive patients with arthralgia (n = 58 serum samples), patients with osteoarthritis (OA; n = 49 serum and 52 SF samples), and healthy individuals (n = 51 serum samples). Results: Reactivity to ROS‐CII among DMARD‐naive patients with early RA was significantly higher than that among patients with ACPA‐positive arthralgia, patients with OA, and healthy control subjects ( P < 0.0001), with 92.9% of serum samples from the patients with early RA binding to anti–ROS‐II. There was no significant difference in anti–ROS‐CII reactivity between ACPA‐positive and ACPA‐negative patients with RA, with 93.8% and 91.6% of serum samples, respectively, binding to ROS‐CII. The sensitivity and specificity of binding to ROS‐CII in patients with early RA were 92% and 98%, respectively. Among patients with established RA, serum reactivity in DMARD nonresponders was significantly higher than that in DMARD responders ( P < 0.01); 58.3% of serum samples from nonresponders and 7.6% of serum samples from responders bound to HOCl‐ROS, while the respective values for SF were 70% and 60%. In patients with longstanding RA, autoreactivity to ROS‐CII changed longitudinally. Conclusion: Autoantibodies to ROS‐CII have the potential to become diagnostic biomarkers of RA
Reumatología I by Paul Emery( Book )

1 edition published in 2002 in Spanish and held by 1 WorldCat member library worldwide

Inflammation in arthritis : phospholipase A2 and the effects of intra-articular therapies by Philip Conaghan( )

1 edition published in 2004 in English and held by 1 WorldCat member library worldwide

Osteoarthritis by Philip Conaghan( )

5 editions published between 2009 and 2012 in English and held by 0 WorldCat member libraries worldwide

moreShow More Titles
fewerShow Fewer Titles
Audience Level
Audience Level
  Kids General Special  
Audience level: 0.24 (from 0.01 for Musculoske ... to 0.99 for Reumatolog ...)

Fast facts : osteoarthritisOsteoarthritis
Alternative Names
Conaghan, P.

Conaghan, P. (Philip G.)

Philip G Conaghan professor of musculoskeletal medicine

Musculoskeletal imagingNew treatments in arthritisOsteoarthritis